E-LIB Suche - Ergebnisse für: Lemonnier, F

1

Treatment with anti CD19 CAR‐T cells is safe and effective ..:

Marieton, E. Robin ; Le Bras, F. ; Malfuson, J....
Hematological Oncology. 41 (2023) S2 - p. 456-457 , 2023

Link: https://doi.org/10.1002/..

2

EARLY CTDNA CLEARANCE AFTER CAR T‐CELL INFUSION PREDICTS OU..:

Delfau‐Larue, M. ; Viailly, P. ; Cartron, G....
Hematological Oncology. 41 (2023) S2 - p. 179-181 , 2023

Link: https://doi.org/10.1002/..

3

Cell‐free DNA sequencing allows the identification of the m..:

Sako, N. ; Delfau, M. ; Bachy, E....
Hematological Oncology. 41 (2023) S2 - p. 338-339 , 2023

Link: https://doi.org/10.1002/..

4

CLONAL ARCHITECTURE OF RELAPSED OR REFRACTORY FOLLICULAR HE..:

Loyaux, R. ; Sako, N. ; Quang, V. Tran...
Hematological Oncology. 41 (2023) S2 - p. 108-110 , 2023

Link: https://doi.org/10.1002/..

5

Validation of Amylo-AFFECT, a self-reported questionnaire t..:

Kharoubi, M. ; Bézard, M. ; Broussier, A....
Archives of Cardiovascular Diseases Supplements. 15 (2023) 1 - p. 39 , 2023

Link: https://doi.org/10.1016/..

6

Real-life evaluation of an algorithm for the diagnosis of c..:

Bézard, M. ; Kharoubi, M. ; Galat, A....
Archives of Cardiovascular Diseases Supplements. 15 (2023) 1 - p. 34 , 2023

Link: https://doi.org/10.1016/..

7

KILT: A RANDOMIZED NON‐COMPARATIVE PHASE II LYSA STUDY OF L..:

Cheminant, M. ; Carras, S. ; Bruneau, J....
Hematological Oncology. 41 (2023) S2 - p. 838-839 , 2023

Link: https://doi.org/10.1002/..

8

EPIGENETIC BASIS AND THERAPY OF FOLLICULAR HELPER T‐CELL LY..:

Lemonnier, F.
Hematological Oncology. 41 (2023) S2 - p. 89-89 , 2023

Link: https://doi.org/10.1002/..

9

A RANDOMIZED PHASE II STUDY OF MB‐CART2019.1 COMPARED TO ST..:

Borchmann, P. ; Vandenberghe, P. ; Urbano‐Ispizua, A....
Hematological Oncology. 41 (2023) S2 - p. 840-841 , 2023

Link: https://doi.org/10.1002/..

10

AXICABTAGENE CILOLEUCEL AS SECOND‐LINE THERAPY FOR LARGE B‐..:

Houot, R. ; Bachy, E. ; Cartron, G....
Hematological Oncology. 41 (2023) S2 - p. 147-148 , 2023

Link: https://doi.org/10.1002/..

11

PB2115: TRIAL IN PROGRESS: A RANDOMIZED PHASE II STUDY OF M..:

Borchmann, P. ; Vandenberghe, P. ; Urbano, A....
HemaSphere. 6 (2022) - p. 1986-1987 , 2022

Link: https://doi.org/10.1097/..

12

Prevalence and determinant of iron deficiency in the three ..:

Jobbe-Duval, A. ; Bézard, M. ; Moutereau, S....
Archives of Cardiovascular Diseases Supplements. 14 (2022) 1 - p. 34 , 2022

Link: https://doi.org/10.1016/..

13

IMPACT OF DUSP22 REARRANGEMENT ON THE PROGNOSIS OF SYSTEMIC..:

Sibon, D ; Bisig, B ; Bonnet, C...
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

14

BASELINE CIRCULATING TUMOUR DNA AND TOTAL METABOLIC TUMOUR ..:

Le Goff, E ; Blanc‐Durand, P ; Roulin, L...
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

15

The health promoting sports club model: An intervention pla..:

Van Hoye, A ; Johnson, S ; Geidne, S...
European Journal of Public Health. 30 (2020) Supplement_5 - p. , 2020

Link: https://doi.org/10.1093/..